ALZHEIMER'S DISEASE AND BRAIN DEVELOPMENT: COMMON MOLECULAR PATHWAYS

Kelly Jordan-Sciutto and Robert Bowser

Department of Pathology, University of Pittsburgh School of Medicine. Pittsburgh, PA 15261

Received 11/9/97 Accepted 11/15/97

6. REFERENCES

1. Braak, H. and E. Braak: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259 (1991)

2. Levy-Lahad, E. and T. Bird: Genetic factors in Alzheimer's disease: a review of recent advances. Ann Neurol 40, 829-840 (1996)

3. Wisniewski, H., J. Wegiel and L. Kotula: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol 22, 3-11 (1996)

4. Hutton, M. and J. Hardy: The presenilins and Alzheimer's disease. Hum Mol Genet 6, 1639-1646 (1997)

5. Haass, C.: Presenilins: Genes for life and death. Neuron 18, 667-690 (1997)

6. Lyras, L., N. Cairns, A. Jenner, P. Jenner and B. Halliwell: An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 63, 2061-2069 (1997)

7. Mattson, M. and R. Rydel: Amyloid ox-tox transducers. Nature 382, 674-675 (1996)

8. Davis, R., S. Miller, C. Herrnstadt, S. Ghosh, E. Fahy, L. Shinobu, D. Galasko, L. Thal, M. Beal, N. Howell and J. WD Parker: Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset alzheimer disease. Proc Natl Acad Sci USA 94, 4526-4531 (1997)

9. Paresce, D., R. Ghosh and F. Maxfield: Microglial cells internalize aggregates of the Alzheimer's disease amyloid B-Protein Via a scavenger receptor. Neuron 17, 553-565 (1996)

10. Yankner, B.: Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 921-932 (1996)

11. Yankner, B., L. Dawes, S. Fisher, L. Villa-Komaroff, M. Oser-Granite and R. Neve: Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-429 (1989)

12 . Yankner, B., L. Duffy and D. Kirschner: Neurotrophic and neurotoxic effects of amyloid B protein: reversal by tachykinin neuropeptides. Science 250, 279-282 (1990a)

13. Yankner, B., A. Caceres and L. Duffy: Nerve growth factor potentiates the neurotoxicity of B amyloid. Proc Natl Acad Sci USA 87, 9020-9023 (1990b)

14. Pike, C., A. Walencewicz, C. Glabe and C. Cotman: In vitro aging of B-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563, 311-314 (1991)

15. Roher, A., M. Ball, S. Bhave and A. Wakade: B-Amyloid from Alzheimer's disease brain inhibits sprouting and survival of sympathetic neurons. Biochem Biophys Res Commun 174, 572-579 (1991)

16. Su, J., G. Deng and C. Cotman: Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 56, 86-93 (1997)

17. Kim, T.-W., W. Pettingell, Y.-K. Jung, D. M. Kovacs and R. Tanzi: Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277, 373-376 (1997)

18. Doan, A., G. Thinakaran, D. Borchelt, H. Slunt, T. Ratovitsky, M. Podlisny, D. Selkoe, M. Seeger, S. Gandy, D. Price and S. Sisodia: Protein topology of Presenlin 1. Neuron 17, 1023-1030 (1996)

19. Walter, J., A. Capell, J. Grunberg, B. Pesold, A. Schindzielorz, R. Prior, M. Podlisny, P. Fraser, P. S. George-Hyslop, D. Selkoe and C. Haass: The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol Med 2, 673-691 (1996)

20. Mattson, M. and Q. Guo: Cell and molecular neurobiology of presenilins: a role for the endoplasmic reticulum in the pathogenesis of Alzheimer's disease. J Neurosci Res 50, 505-513 (1997)

21. Prodlisny, M., M. Citron, P. Amarante, R. Sherrington, W. Xia, J. Zhang, T. Diehl, G. Levesque, P. Fraser, C. Haass, E. Koo, P. Seubert, P. S. G. Hyslop, D. Teplow and D. Selkoe: Presenilin proteins undergo heterogeneous endoproteolysis between Thr 291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Disease 3, 325-337 (1997)

22. Wisniewski, T., W. Dowjat, B. Permanne, J. Palha, A. Kumar, G. Gallo and B. Frangione: Presenilin 1 is associated with Alzheimer's disease amyloid. Am J Pathol 151, 601-610 (1997)

23. GM Murphy, J., L. Forno, W. Ellis, D. Nochlin, E. Levy-Lahad, P. Poorkaj, T. Bird, Z. Jiang and B. Cordell: Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease. Am J Pathology 149, 1839-1846 (1996)

24. Weber, L. L., M. Leissring, A. Yang, C. Glabe, D. Cribbs and F. LaFerla: Presenilin-1 Immunoreactivity is localized intracellularly in Alzheimer's diease brain, but not detected in amyloid plaques. Exp Neurol 143, 37-44 (1997)

25. Busciglio, J., H. Hartman, A. Lorenzo, C. Wong, K. Baumann, B. Sommer, M. Staufenbiel and B. Yankner: Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangels in Alzheimer's disease. J Neurosci 17, 5101-5107 (1997)

26. Li, J., M. Xu, H. Zhou, J. Ma and H. Potter: Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90, 917-927 (1997)

27. Scheuner, D., C. Eckman, M. Jensen, X. Song, M. Ctron, N. Suzuki, T. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Preskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe and S. Younkin: Secreted amyloid B protein similar to that in the senile plaques of Alzheimer;s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2, 864-870 (1996)

28. Duff, K., C. Eckman, C. Zehr, X. Yu, C.-m. Prada, J. Perez-tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy and S. Younkin: Increased amyloid-B42(43) in brains of mice expressing mutant presenilin 1. Nature 383, (1996)

29. Borchelt, D., G. Thinakaran, C. Eckman, M. Lee, B. Davenport, T. Ratovitsky, C.-M. Prada, B. Kim, S. Seekins, D. Yager, H. Slunt, R. Wang, M. Seeger, A. Levey, S. gandy, N. Copeland, N. Jenkins, D. Price, S. Younkin and S. Sisodia: Familial Alzheimer's disease-linked presenilin 1 variants elevate AB-1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013 (1996)

30. Weidemann, A., K. Paliga, U. Durrwang, C. Czech, G. Evin, C. Masters and K. Beyreuther: Formation of stable complexes between two Alzheimer's disease gene products: presenilin-2 and beta-amyloid precursor protein. Nat Med 3, 328-332 (1997)

31.. Xia, W., J. Zhang, R. Perez, E. Koo and D. Selkoe: Interaction between amyloid precusor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer's disease. Proc Natl Acad Sci USA 94, 8208-8213 (1997)

32. Waragai, M., I. Imafuku, S. Takeuchi, I. Kanazawa, F. Oyama, Y. Udagawa, M. Kawabata and H. Okazawa: Presenilin 1 binds to amyloid precursor protein directly. Biochem Biophys Res Commun 239, 480-482 (1997)

33. Davies, P.: Neuronal Abnormalities, Not Amyloid, Are the Cause of Dementia in Alzheimer's Disease In: Alzheimer's Disease , Eds: R. Terry, R. Katzman and K. Bick, Raven Press, New York 327-334 (1994)

34. Kosik, K. and S. Greenberg: Tau protein and Alzheimer's disease In: Alzheimer's Disease , Eds: R. Terry, R. Katzman and K. Bick, Raven Press, New York 335-344 (1994)

35. Mandelkow, E.-M., O. Schweers, G. Drewes, J. Biernat, N. Gustke, B. Trnczek and E. Mandelkow: Structure, microtubule interactions, and phosphorylation of tau protein. Ann N Y Acad Sci 777, 97-107 (1996)

36. Gomez-Isla, R., R. Hollister, H. West, S. Mui, J. Growdon, R. Petersen, J. E. Parisi and B. Hyman: Neuronal loss correlates with by exceeds Neurofibrillary tangles in Alzheimer's disease. Ann Neurol 41, 17-24 (1997)

37. Vincent, I., M. Rosado and P. Davies: Mitotic mechanisms in Alzheimer's Disease? J Cell Biol 132, 413-425 (1996)

38. Schipper, H., S. Cisse and E. Stopa: Expression of Heme Oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 37, 758-768 (1995)

39. Subbarao, K., J. Richardson and L. Ang: Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 55, 338-342 (1990)

40. Palmer, A. and M. Burns: Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res 645, 338-342 (1994)

41. Perrin, R., S. Braincon and C. Jeandel: Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase, and catalase in Alzheimer's disease: A case-control study. Gerontology 36, 306-313 (1990)

42. Jeandel, C., M. Nocolas and F. Dubois: Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 36, 306-313 (1989)

43. Zemlan, F., O. Thienhaus and H. Bosmann: Superoxide dismutase activity in Alzheimer's diease: possible mechanism for paired helical filament formation. Brain Res 476, 160-162 (1989)

44. Yan, S., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, D. Stern and A. Schmidt: RAGE and the amyloid-B peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-716 (1996)

45. Khoury, J., S. Hickman, C. Thomas, L. Cao, S. Silverstein and J. Loike: Scavenger receptor-mediated adhesion of microglia to B-amyloid fibrils. Nature 382, 716-719 (1996)

46. McGeer, P. and E. McGeer: Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann N Y Acad Sci 777, 213-220 (1996)

47. McGeer, P., M. Schulzer and E. McGeer: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47, 425-32 (1997)

48. Breitner, J.: The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Ann Rev Med 47, 401-411 (1996)

49. Stewart, W., C. Kawas, M. Corrada and E. Metter: Risk of Alzheimer's disease and duration of NSAID use. Neurology 48, 626-632 (1997)

50. Dickson, D., S. Lee, L. Mattiace, S. Yen and C. Brosnan: Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7, 75-83 (1993)

51. Zhang, P., E. Hirsch, P. Damier, C. Duyckaerts and F. Javoy-Agid: c-fos protein-like immunoreactivity: Distribution in the human brain and over-expression in the hippocampus of patients with Alzheimers' disease. Neuroscience 46, 9-21 (1992)

52. Anderson, A., J. Su and C. Cotman: DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 16, 1710-1719 (1996)

53. Anderson, A., B. Cummings and C. Cotman: Increased immunoreactivity for Jun-and Fos-related proteins in Alzheimer's disease: Assoication with pathology. Exp Neurol 125, 286-295 (1994)

54. Kaltschmidt, B., M. Uherek, B. Volk, P. Baeuerle and C. Kaltschmidt: Transcription factor NF-kB is activated in primary neurons by amyloid B peptides and in neurons surrounding early plaques from patients with Alzheimer's disease. Proc Natl Acad Sci USA 94, 2642-2647 (1997)

55. MacGibbon, G., P. Lawlor, M. Walton, E. Sirimanne, R. Faull, B. Synek, E. Mee, B. Conner and M. Dragunow: Expression of Fos, Jun, and Krox family proteins in Alzheimer's disease. Exp Neurol 147, 316-332 (1997)

56. Morgan, J. and T. Curran: Stimulus-transcription coupling in nervous system, involvement of inducible proto-oncogenes Fos and Jun. Annu Rev Neurosci 14, 431-451 (1991)

57. Colotta, F., N. Polentarutti, M. Sironi and A. Montovani: Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem 267, 18278-18283 (1992)

58. Dragunow, M., D. Young, P. Hughes, G. MacGibbon, P. Lawlor, K. Singleton, E. Sirimanne, E. Beilharz and P. Gluckman: Is c-jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury? Mol Brain Res 18, 347-352 (1993)

59. Estus, S., W. Zaks, R. Freeman, M. kGruda, R. Bravo and J. EM Johnson: Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127, 1717-1727 (1994)

60. Kyriakis, J., P. Banerjee, E. Mikolakaki, T. Dai, E. Ruble, M. Ahmad, J. Avruch and J. Woodgett: The stress-activated protein kinase subfamily of c-jun kinases. Nature 369, 156-160 (1994)

61. Derijard, B., M. Hibi, I.-H. Wu, T. Barrett, B. Su, T. Deng, M. Karin and R. Davis: JNK1: a protein kinase stimulated by UV light and HA-ras that binds and phosphorylates teh c-jun activation domain. Cell 76, 1025-1037 (1994)

62. Halazonetis, T., K. Geofopoulos, M. Greenberg and P. Leder: c-Jun dimerizes with itself and with c-fos, forming complexes of different DNA binding affinities. Cell 55, 917-924 (1988)

63. Chiu, R., W. Boyule, J. Meek, T. Smeal, T. Hunter and M. Karin: The c-Fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54, 541-552 (1988)

64. Lemaire, P., O. Revelant, R. Bravo and P. Charnay: Two mouse genes encoding potential transcription factors with identical DNA-binding domains are actviated by growth factors is cultured cells. Proc Natl Acad Sci USA 85, 4691-4695 (1988)

65. Richardson, C., W. Tate, S. Mason, P. Lawlor, M. Dragunow and W. Abraham: Correlation between the induction of an immediate early gene zif/268, and long-term potentiation in the dentate gyrus. Brain Res 580, 147-154 (1992)

66. Abraham, W., M. Dragunow and W. Tate: The role of immediate early genes in the stabilization of long-term potentiation. Mol Neurobiol 5, 297-314 (1992)

67. Verma, I., J. Stevenson, E. Schwarz, D. Antwerp and S. Miyamoto: Rel/NFkB/IkB family: intimate tales of association and dissociation. Genes Dev 9, 2723-2735 (1995)

68. Baeuerle, P. and T. Henkel: Function and activation of NF-kapa B in the immune system. Annu Rev Immunol 12, 141-179 (1994)

69. Stancovski, I. and D. Baltimore: NF-kB Activation: The IkB kinase revealed? Cell 91, 199-302 (1997)

70. Barger, S., D. Horster, K. Furukawa, Y. Goodman, J. Krieglstein and M. Mattson: Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a Kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci USA 92, 9328-9332 (1995)

71. Rosette, C. and M. Karin: Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kB. J Cell Biol 128, 1111-1119 (1995)

72. Kaltschmidt, C., B. Kaltschmidt and P. Baeuerle: Brain synaptosomes contain inducible forms of the transcription factor NF-kB. Mech Dev 43, 135-147 (1993)

73. Pyrc, J., K. Moberg and D. Hall: Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoter. Biochemistry 31, 4102-4110 (1992)

74. Bossone, S., C. Asselin, A. Patel and K. Marcu: MAZ, a zinc finger protein, binds to c-myc and C2 gene sequences regulating transcriptional initiation and termination. Proc Natl Acad Sci USA 89, 7452-7456 (1992)

75. Tsutsui, H., O. Sakatsume, K. Itakura and K. Yokoyama: Members of the MAZ family: A novel cDNA clone for MAZ from human pancreatic islet cells. Biochem Biophys Res Commun 226, 801-809 (1996)

76. Ross, M.: Cell division and the nervous system: regulating the cycle from neural differentiation to death. Trends Neurosci 19, 62-68 (1996)

77. Clevenger, C., A. L. Epstein and K. D. Bauer: Modulation of the nuclear antigen p105 as a function of cell-cycle progression. J Cell Physiol 130, 336-343 (1987)

78. Liu, W.-K., R. T. Williams, F. L. Hall, D. W. Dickson and S.-H. Yen: Detection of a cdc2-related kinase associated wih Alzheimer paired helical filaments. Am J Pathol 146, 228-238 (1995)

79. Nagy, Z., M. Esiri, A.-M. Cato and A. D. Smith: Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 94, 6-15 (1997)

80. Nakamura, S., Y. Kawamoto, S. Nakano, I. Akiguchi and J. Kimura: p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease. Acta Neuropathol 94, 153-157 (1997)

81. Smith, T. and C. Lippa: Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 54, 297-303 (1995)

82. McShea, A., P. Harris, K. Webster, A. Wahl and M. Smith: Abnormal Expression of the cell cycle regulators p16 and cdk4 in Alheimer's disease. Am J Pathol 150, 1933-1939 (1997)

83. Suzuki, T., M. Oishi, D. R. Marshck, A. Czernik, A. Nairn and P. Greengard: Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J 13, 1114-1122 (1994)

84. Pines, J.: Cyclins, CDKs and cancer. Semin Cancer Biol 6, 63-72 (1995)

85. Massague, J. and K. Polyak: Mammalian antiproliferative signals and their targets. Curr Opin Genet Dev 5, 91-96 (1995)

86. Ledesma, M., I. Correas, J. Avila and J. Diaz-Nido: Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's desease. FEBS Lett 308, 218-224 (1992)

87. Baumann, K., E.-M. Mandelkow, J. Biernat, H. Piwnica-Worms and E. Mandelkow: Abnormal Alzheimer's-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett 336, 417-424 (1993)

88. Imahori, K. and T. Uchida: Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J Biochem 121, 179-188 (1997)

89. Lew, J., Q. Huang, Z. Qi, R. Winfein, R. Aebersold, T. Hunt and J. Wang: A brain specific activator of cyclin dependent kinase 5. Nature 371, 423-6 (1994)

90. Tsai, L., T. Takahashi, V. C. Jr and E. Harlow: Activity and expression pattern of cyclin dependent kinase 5 in embryonic mouse nervous system. Development 119, 1029-40 (1993)

91. Tsai, L., I. Delalle, V. C. Jr, T. Chae and E. Harlow: p35 is a neural-specific regulatory subunit of cyclin dependent kinase 5. Nature 371, 419-23 (1994)

92. El-Deiry, W., T. Tokino, V. Belculesco, D. Levy, R. Parosns, J. Trent, D. Lin, W. Mercer, K. Kinzler and B. Vogelstein: WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993)

93. Dulic, V., W. Kaufmann, S. Wilson, T. Tisty, E. Lees, W. Harper, S. Elledge and S. Reed: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023 (1994)

94. Kitamura, Y., S. Shimohama, W. Kamoshima, Y. Matsuoka, Y. Nomura and T. Taniguchi: Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 232, 418-421 (1997)

95. Nagy, Z., M. Esiri and A. Smith: Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol 93, 294-300 (1997)

96. Lee, E. Y.-P., C.-Y. Chang, N. Hu, Y.-C. J. Wang, C.-C. Lai, K. Herrup, W.-H. Lee and A. Bradley: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294 (1992)

97. Sun, N., Z. Tan, S. Sakhi, L. Lemay and S. Schreiber: Increased expression of cell cycle genes in Alzheimer's disease. 27th Annual Society for Neuroscience Meeting. New Orleans, LA 2, 1987 (1997)

98. Kouzarides, T.: Transcriptional control by the retinoblastoma protein. Semin Cancer Biol 6, 91-98 (1995)

99. Lowe, S., H. Ruley, T. Jacks and D. Housman: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74, 957-967 (1993)

100. Rao, L., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer and E. White: The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19 kDa and Bcl-2 proteins. Proc Natl Acad Sci USA 89, 7742-7746 (1992)

101. Malsiah, E., M. Mallory, M. Alford, L. Hansen and T. Saitoh: Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease. Lab Invest 69, 562-569 (1993)

102. Yaar, M., S. Zhai, P. Pilch, S. Doyle, P. Eisenhauer, R. Fine and B. Gilchrest: Binding of Beta-amyloid to the p75 neurotrophin receptor induces apoptosis. J Clin Invest 100, 2333-2340 (1997)

103. Lassman, H., C. Bancher, H. Breitschopf, J. Wegiel, M. Bobinski, K. Jellinger and H. Wisniewski: Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89, 35-41 (1995)

104. Goedert, M., M. Spillantini, M. Potier, J. Ulrich and R. Crowther: Cloning and sequencing of the cDNA encoding an isofrom of microtubule-assoicated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8, 393-399 (1989)

105. Goedert, M., M. Spillantini, R. Jakes, D. Rutherford and R. Crowther: Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3, 519-526 (1989)

106. Ksiezak-Reding, H., P. Davies and S.-H. Yen: Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain. J Biol Chem 263, 7943-7947 (1988)

107. Bramblett, G., M. Goedert, R. Jakes, S. Merrick, J. Trojanowski and V.-Y. Lee: Abnormal tau phosphorylation at ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 1089-1099 (1993)

108. Brion, J.-P., C. Smith, A.-M. Couck, J.-M. Gallo and B. Anderton: Developmental changes in tau phosphorylation: Fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J Neurochem 61, 2071-2079 (1993)

109. Lovestone, S. and C. Reynolds: The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78, 309-324 (1997)

110. Geddes, J., J. Wong, B. Choi, R. Kim, C. Cotman and F. Miller: Increased expression of the embryonic form of a developmentally regulated mRNA in Alzheimer's disease. Neurosci Lett 109, 54-61 (1990)

111. Kondo, T., T. Shirasawa, Y. Itoyama and H. Mori: Embryonic genes expressed in Alzheimer's disease brains. Neurosci Lett 209, 157-160 (1996)

112. Levitan, D. and I. Greenwald: Facilitation of Lin-12-mediated signalling by sel-12, a Caenorhabditis Elegans S182 gene. Nature 377, 351-354 (1995)

113. Levitan, D., T. Doyle, D. Brousseau, M. Lee, G. Thinakaran, H. Slunt, S. Sisodia and I. Greenwald: Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci USA 93, 14940-14944 (1996)

114. Shen, J., R. Bronson, B. F. Chen, W. Xia, D. J. Selkoe and S. Tonegawa: Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639 (1997)

115. Wong, P., H. Zheng, H. Chen, M. Becher, D. Sirinathsinghji, M. Trumbauer, H. Chen, D. Price, L. V. d. Ploeg and S. S. Sisodia: Presenilin 1 is required for Notch 1 and Dll 1 expression in the paraxial mesoderm. Nature 387, 288-292 (1997)

116. Bowser, R., A. Giambrone and P. Davies: A novel developmentally regulated protein, FAC1, is contained in plaques of the neocortex in Alzheimer's disease. Neurobiol Aging 15, S122 (1994)

117. Schoonover, S., P. Davies and R. Bowser: Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease. J Neuropathol Exp Neurol 55, 444-455 (1996)

118. Zhu, P. and R. Bowser: Identification and analysis of the complete cDNA sequence for the human FAC1 gene. Biochim Biophys Acta In Press, (1996)

119. DeWitt, D. and J. Silver: Regenerative failure: A potential mechanism for neuritic dystrophy in Alzheimer's disease. Exp Neurol 142, 103-110 (1996)

120. Styren, S., R. Bowser and S. DeKosky: Expression of fetal ALZ-50 reactive clone 1 (FAC1) in dentate gyrus following entorhinal cortex lesion. J Comp Neurol 386, 555-561 (1997)

121. Mizuguchi, M., O. Sohma, S. Takashima, K. Ideda, M. Yamada, N. Shiraiwa and S. Ohta: Immunochemical and immunohistochemical localization of Bcl-x protein in the rat central nervous system. Brain Res 712, 282-286 (1996)

122. Sohma, O., M. Mizuguchi, S. Takashima, M. Yamada, K. Ikeda and S. Ohta: High expression of bcl-x protein in developming human cerebellar cortex. J Neurosci Res 43, 175-182 (1996)

123. Motoyama, M., F. Wang, K. Roth, H. Sawa, K. Nakayama, K. Nakayama, I. Negshi, S. Senju, Q. Zheng, S. Fujii and D. Loh: Massive cell death of immature hematopoietic cells and neurons in bcl-x-deficient mice. Scinece 267, 1506-1510 (1995)

124. Drache, B., G. Diehl, K. Beyreuther, L. Perlmutter and G. Konig: Bcl-xl-specific antibody labels activated microglia assoicated with Alzheimer's disease and other pathological states. J Neurosci Res 47, 98-108 (1997)

125. O'Barr, S., J. Schultz and J. Rogers: Expression of the protooncogene bcl-2 in Alzheimer's disease brain. Neurobiol Aging 17, 131-136 (1996)